Literature DB >> 9753285

Immune phenotype of chronic liver disease.

A J Czaja1, R M dos Santos, A Porto, P J Santrach, S B Moore.   

Abstract

Immune disorders in chronic liver disease may reflect common host propensities or disease-specific factors. Our aim was to determine the principal bases for these expressions. Four hundred fifty-one patients with various chronic liver diseases were assessed prospectively for concurrent immune disorders. Individuals with immune diseases were more frequently women (73% vs 60%, P = 0.02) and they had HLA DR4 more often than counterparts with other HLA (46% vs 23%, P = 0.000008). The association between HLA DR4 and immune disease was apparent within individual liver diseases and within different categories of liver disease. Women with HLA DR4 had a higher frequency of immune disease than women without HLA DR4 (52% vs 22%, P < or = 0.000001), and they also had immune diseases more commonly than DR4-positive men (52% vs 31%, P = 0.03). DR4-positive men, however, had higher frequencies of immune disease than DR4-negative men, especially in the nonimmune types of liver disease (26% vs 4%, P = 0.002). We conclude that HLA DR4 and female gender constitute an immune phenotype that is an important basis for autoimmune expression in chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9753285     DOI: 10.1023/a:1018836004279

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  48 in total

Review 1.  Autoantibodies.

Authors:  A J Czaja
Journal:  Baillieres Clin Gastroenterol       Date:  1995-12

2.  Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis.

Authors:  M D Strettell; P T Donaldson; L J Thomson; P J Santrach; S B Moore; A J Czaja; R Williams
Journal:  Gastroenterology       Date:  1997-06       Impact factor: 22.682

3.  A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules.

Authors:  J H Brown; T Jardetzky; M A Saper; B Samraoui; P J Bjorkman; D C Wiley
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

4.  Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis.

Authors:  A J Czaja; M D Strettell; L J Thomson; P J Santrach; S B Moore; P T Donaldson; R Williams
Journal:  Hepatology       Date:  1997-02       Impact factor: 17.425

5.  Age and sex associations of 40 autoimmune diseases.

Authors:  P B Beeson
Journal:  Am J Med       Date:  1994-05       Impact factor: 4.965

6.  A stable sheep cell preparation for detecing thyroglobulin auto-antibodies and its clinical applications.

Authors:  A J FULTHORPE; I M ROITT; D DONIACH; K COUCHMAN
Journal:  J Clin Pathol       Date:  1961-11       Impact factor: 3.411

7.  Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.

Authors:  A J Czaja; H A Carpenter; M P Manns
Journal:  Gastroenterology       Date:  1993-11       Impact factor: 22.682

8.  Significance of HLA DR4 in type 1 autoimmune hepatitis.

Authors:  A J Czaja; H A Carpenter; P J Santrach; S B Moore
Journal:  Gastroenterology       Date:  1993-11       Impact factor: 22.682

9.  Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis.

Authors:  A J Czaja; M P Manns; H A Homburger
Journal:  Gastroenterology       Date:  1992-10       Impact factor: 22.682

10.  Steroid sex hormones regulate the release of tumor necrosis factor by macrophages.

Authors:  T C Chao; P J Van Alten; J A Greager; R J Walter
Journal:  Cell Immunol       Date:  1995-01       Impact factor: 4.868

View more
  22 in total

Review 1.  Autoimmune hepatitis and its variant syndromes.

Authors:  Z Ben-Ari; A J Czaja
Journal:  Gut       Date:  2001-10       Impact factor: 23.059

Review 2.  Genetic bases of autoimmune hepatitis.

Authors:  Albert J Czaja; Derek G Doherty; Peter T Donaldson
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

3.  Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?

Authors:  Satoru Yatsuji; Etsuko Hashimoto; Hiroyuki Kaneda; Makiko Taniai; Katsutoshi Tokushige; Keiko Shiratori
Journal:  J Gastroenterol       Date:  2005-12       Impact factor: 7.527

Review 4.  Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2017-07-14       Impact factor: 3.199

5.  Performance parameters of the conventional serological markers for autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-12-03       Impact factor: 3.199

Review 6.  Autoantibody-negative autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-12-21       Impact factor: 3.199

Review 7.  Cryptogenic chronic hepatitis and its changing guise in adults.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-06-07       Impact factor: 3.199

Review 8.  Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.

Authors:  Albert J Czaja; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

Review 9.  Drug therapy in the management of type 1 autoimmune hepatitis.

Authors:  A J Czaja
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

10.  Study of nonstandard auto-antibodies as prognostic markers in auto immune hepatitis in children.

Authors:  Lerine B El-Din Elshazly; Azza M Youssef; Nermine H Mahmoud; Mona M Ibrahim
Journal:  Ital J Pediatr       Date:  2009-07-20       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.